Reciprocal modulation of astrocyte stellation by thrombin and protease nexin-1.
When cultured astroglia are treated with agents that elevate intracellular cyclic AMP, they become process-bearing stellate cells and resemble differentiated astrocytes in vivo. Thrombin rapidly reversed the stellation induced by dibutyryl cyclic AMP, forskolin, or isoproterenol in cultured rat astrocytes; half-maximal and maximal effects occurred at 0.5 and 8 pM, respectively. The proteolytic activity of thrombin was required for stellation reversal, as thrombin derivatized at its catalytic site serine with a diisopropylphospho group was inactive. Two thrombin inhibitors, protease nexin-1 and hirudin, blocked and reversed the effect of thrombin. The stellation reversal effect of thrombin was specific, as 300-1,000-fold higher concentrations of other serine proteinases, including plasmin, urokinase, trypsin, and T cell serine proteinase-1, were ineffective. Thrombin is a mitogen for astrocytes at concentrations in excess of 30 pM. Thrombin increased both cell number and ornithine decarboxylase activity, an early marker for mitogenic stimulation, in astrocyte cultures. The lowest thrombin concentrations that completely reversed astrocyte stellation, however, did not increase ornithine decarboxylase activity. Moreover, several other mitogens for astrocytes did not reverse dibutyryl cyclic AMP-induced stellation. Thus, the stellation reversal effect of thrombin is distinct from the mitogenic response.
Cavanaugh
K P
KP
Department of Biochemistry, College of Medicine, University of California, Irvine 92717.
Gurwitz
D
D
Cunningham
D D
DD
Bradshaw
R A
RA
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D016564:Amyloid beta-Protein Precursor; D000818:Animals; D001253:Astrocytes / Q000187:drug effects / Q000648:ultrastructure*; D003994:Bucladesine / Q000494:pharmacology; D002352:Carrier Proteins / Q000494:pharmacology*; D002452:Cell Count / Q000187:drug effects; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D009955:Ornithine Decarboxylase / Q000378:metabolism; D009994:Osmolar Concentration; D058255:Protease Nexins; D011956:Receptors, Cell Surface; D013917:Thrombin / Q000494:pharmacology*
D016564:Amyloid beta-Protein Precursor; D002352:Carrier Proteins; D058255:Protease Nexins; D011956:Receptors, Cell Surface; D003994:Bucladesine; D013917:Thrombin; D009955:Ornithine Decarboxylase; D015056:1-Methyl-3-isobutylxanthine